Title:
白人個体群の個体の大多数により認識され得るエプスタイン-バーウイルスのI型及びII型潜伏期抗原のTCD4+エピトープ、及びその適用
Document Type and Number:
Japanese Patent JP4972562
Kind Code:
B2
Abstract:
The invention relates to immunogenic peptides from EBV type I and II latency antigens, comprising at least one T CD4+ epitope which can be recognized by the majority of individuals in the Caucasian population. The invention also relates to the diagnostic and therapeutic applications of same.
Inventors:
Punkle, Veronique
Auri Ault, Cloud
Depil, Stefan
Mailer, bernard
Morales, Olivier
Meunier, Gaetane
Auri Ault, Cloud
Depil, Stefan
Mailer, bernard
Morales, Olivier
Meunier, Gaetane
Application Number:
JP2007553650A
Publication Date:
July 11, 2012
Filing Date:
February 02, 2006
Export Citation:
Assignee:
ECOLE NORMALE SUPERIEURE
International Classes:
C12N15/09; A61K39/245; A61K48/00; A61P31/22; C07K7/08; C07K14/05; C07K19/00; C12N1/15; C12N1/19; C12N1/21; C12N5/10; C12Q1/02
Other References:
J. Immunol.,2002年,vol.169, no.4,pp.2172-2179
Cancer Res.,2002年,vol.62, no.24,pp.7195-7199
J. Virol.,2004年,vol.78, no.2,pp.768-778
Cancer Res.,2002年,vol.62, no.24,pp.7195-7199
J. Virol.,2004年,vol.78, no.2,pp.768-778
Attorney, Agent or Firm:
Shintaro Nogawa